<DOC>
	<DOCNO>NCT02144584</DOCNO>
	<brief_summary>This randomize double blind placebo-controlled pilot study use repeat measure design participant acute ischemic stroke upper extremity weakness randomize either drug placebo</brief_summary>
	<brief_title>Memantine Enhanced Stroke Recovery</brief_title>
	<detailed_description>This randomize double blind placebo-controlled pilot study use repeat measure design participant acute ischemic stroke upper extremity weakness randomize either drug placebo , complete therapy , complete outcome assessment baseline , 4 , 12 week post-stroke . Target enrollment 10 patient per group adaptive randomization use assist equal representation pre-stroke selective serotonin reuptake inhibitor ( SSRI ) use motor severity ( Fugl-Meyer score ) arm . The primary purpose pilot study measure adverse event , drop-out rate , feasibility trial conductance , establishment effect size group order power large efficacy trial University Utah . An intention treat model use study .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>1 . Age &gt; 18 year old 2 . Randomization 38 day stroke symptom onset 3 . Arm weakness severe enough warrant inpatient outpatient occupational therapy 4 . Able voluntarily move wrist digit affect UE 5 . Living independently prior stroke 6 . Imageconfirmed ischemic stroke ( MRI CT ) 7 . Supratentorial location stroke 8 . FuglMeyer Score 55 less 9 . Ability swallow pill 1 . Hemorrhagic stroke , subarachnoid hemorrhage , cause symptom ischemic stroke 2 . Infratentorial location stroke ( brainstem cerebellum ) 3 . NIH Stroke Scale &gt; 20 time randomization 4 . History dementia interfere rehabilitation 5 . Pre poststroke use memantine amantadine 6 . Contraindications take memantine pill form 7 . History prior clinical stroke residual symptom side current symptom would interfere outcome study 8 . Documented severe renal impairment ( CrCl &lt; 30 ml/min ) Blood test perform prior study procedure ensure patient renal impairment do part clinical care . 9 . Moribund expect live 6 month 10 . Severe cognitive deficit premorbid function cause inaccurate neurologic assessment inability complete initial assessment 11 . Comorbid neurologic disease would interfere result include limited Multiple Sclerosis , neurodegenerative disease , spinal cord disease , central nervous system cancer . 12 . Documented severe hepatic impairment ( ChildPugh score &gt; 6 ) severe hepatic disease ( hepatitis ) 13 . Patients pregnant breast feed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>memantine</keyword>
	<keyword>upper extremity weakness</keyword>
	<keyword>motor recovery</keyword>
</DOC>